
Precision Oncology Shifts Toward Combination Strategies, Changing Therapy Development
Cancer treatment is evolving from single-agent approaches to combination therapies targeting multiple biological pathways, with companies like Lixte Biotechnology developing compounds like LB-100 to enhance existing treatments.
Read full story






















